¹⁸F-FDG PET/CT as a tool for the assessment of therapeutic response in a patient with systemic sarcoidosis

Rev Esp Med Nucl Imagen Mol (Engl Ed). 2023 Jan-Feb;42(1):48-50. doi: 10.1016/j.remnie.2022.05.005. Epub 2022 Oct 14.

Authors

M Mangas Losada¹, A Cabrera Villegas², I García Megías¹, L Romero Robles¹, X Boulvard Chollet¹, R Ramirez Lasanta¹

Affiliations

¹ Servicio de Medicina Nuclear, Hospital San Pedro. Centro de Investigaciones Biomédicas de la Rioja, Logroño, La Rioja, Spain.
² Servicio de Medicina Nuclear, Hospital San Pedro. Centro de Investigaciones Biomédicas de la Rioja, Logroño, La Rioja, Spain. Electronic address: acvillegas@riojasalud.es.

PMID: 36253241
DOI: 10.1016/j.remnie.2022.05.005

No abstract available

MeSH terms

Fluorodeoxyglucose F18
Humans
Positron Emission Tomography Computed Tomography*
Positron-Emission Tomography
Sarcoidosis* / diagnostic imaging

Substances

Fluorodeoxyglucose F18